A. Vlahova

441 total citations
13 papers, 164 citations indexed

About

A. Vlahova is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, A. Vlahova has authored 13 papers receiving a total of 164 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in A. Vlahova's work include Advanced Radiotherapy Techniques (2 papers), Breast Cancer Treatment Studies (2 papers) and Prostate Cancer Treatment and Research (2 papers). A. Vlahova is often cited by papers focused on Advanced Radiotherapy Techniques (2 papers), Breast Cancer Treatment Studies (2 papers) and Prostate Cancer Treatment and Research (2 papers). A. Vlahova collaborates with scholars based in Bulgaria, Malta and Albania. A. Vlahova's co-authors include Tihomir Dikov, S. Christova, Radka Kaneva, Vanio Mitev, A. Mitkova, Elenko Popov, Darina Kachakova, I Popov, Vasil Atanasov and Nikola Burdzhiev and has published in prestigious journals such as BMC Cancer, Forensic Science International and European Journal of Surgical Oncology.

In The Last Decade

A. Vlahova

11 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Vlahova Bulgaria 5 100 89 29 17 16 13 164
Paola Rojas Argentina 5 63 0.6× 31 0.3× 15 0.5× 6 0.4× 69 4.3× 7 174
Katherine L. Morel Australia 7 97 1.0× 40 0.4× 43 1.5× 3 0.2× 26 1.6× 11 140
Emily N. Devericks United States 6 175 1.8× 58 0.7× 11 0.4× 3 0.2× 62 3.9× 7 235
Elisabeth Strack Germany 5 60 0.6× 41 0.5× 24 0.8× 2 0.1× 32 2.0× 5 127
Timothy Hagan United States 3 52 0.5× 20 0.2× 14 0.5× 2 0.1× 26 1.6× 5 96
Christopher Boniface United States 5 48 0.5× 44 0.5× 10 0.3× 6 0.4× 16 1.0× 11 84
Forough Abbasi United States 7 114 1.1× 40 0.4× 12 0.4× 2 0.1× 46 2.9× 15 173
Hermon Kihshen United States 2 183 1.8× 110 1.2× 26 0.9× 16 1.0× 2 231
Chi‐Wen Tu Taiwan 8 52 0.5× 31 0.3× 19 0.7× 1 0.1× 43 2.7× 21 141
Tingting Xie China 5 83 0.8× 97 1.1× 13 0.4× 22 1.4× 6 149

Countries citing papers authored by A. Vlahova

Since Specialization
Citations

This map shows the geographic impact of A. Vlahova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Vlahova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Vlahova more than expected).

Fields of papers citing papers by A. Vlahova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Vlahova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Vlahova. The network helps show where A. Vlahova may publish in the future.

Co-authorship network of co-authors of A. Vlahova

This figure shows the co-authorship network connecting the top 25 collaborators of A. Vlahova. A scholar is included among the top collaborators of A. Vlahova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Vlahova. A. Vlahova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Yordanov, Angel, et al.. (2025). Prognosis of rare histological subtypes of breast cancer – insights from the Bulgarian National Cancer Registry. European Journal of Surgical Oncology. 51(4). 109712–109712.
2.
Vlahova, A., et al.. (2023). Finegoldia magna and Mucorales molds co-infection in a severe case of SARS-CoV-2 disease. The Journal of Infection in Developing Countries. 17(9). 1231–1236. 1 indexed citations
4.
Vlahova, A., et al.. (2019). A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?. Forensic Science International. 297. 372–377. 22 indexed citations
5.
Atanasova, Mariyana, et al.. (2019). Intraoperative radiotherapy with balloon-based electronic brachytherapy system – First Bulgarian experience in breast cancer patients. Physica Medica. 68. 155–155. 1 indexed citations
6.
Vlahova, A., et al.. (2019). Long-Term Survival and Complete Response to Anastrozole in Breast Cancer Patient With Cutaneous Metastases Only. Anticancer Research. 39(8). 4393–4398. 3 indexed citations
7.
Vlahova, A., et al.. (2019). Clinical application of impression cytology. 63(2). 17–17.
8.
Vlahova, A., et al.. (2016). A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma. World Journal of Surgical Oncology. 14(1). 287–287. 5 indexed citations
9.
Kachakova, Darina, A. Mitkova, Elenko Popov, et al.. (2016). Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients. TURKISH JOURNAL OF MEDICAL SCIENCES. 46(3). 626–640. 8 indexed citations
10.
Mitkova, A., A. Vlahova, Spartak Valev, et al.. (2015). Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients. BMC Cancer. 15(1). 523–523. 16 indexed citations
11.
12.
Kachakova, Darina, A. Mitkova, Elenko Popov, et al.. (2014). Combinations of Serum Prostate-Specific Antigen and Plasma Expression Levels of let-7c, miR-30c, miR-141, and miR-375 as Potential Better Diagnostic Biomarkers for Prostate Cancer. DNA and Cell Biology. 34(3). 189–200. 99 indexed citations
13.
Kachakova, Darina, A. Mitkova, Elenko Popov, et al.. (2014). Evaluation of the clinical value of the newly identified urine biomarker HIST1H4K for diagnosis and prognosis of prostate cancer in Bulgarian patients.. PubMed. 18(3). 660–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026